Moderna, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Moderna, Inc. (MRNA), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are MRNA insiders buying or selling?
Moderna, Inc. insiders reported 3 open-market buys ($7.0M) and 818 sells ($3.7B) across 821 Form 4 filings — a net selling position of $3.7B.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 16, 2026)
Insider sentiment
Net sellingNet insider flow of $3.7B in net selling.
Recent MRNA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Stephen Hoge | President | Sale | 53.3K | $67.60 | $3.6M |
| Jun 17, 2026 | Stephen Hoge | President | Sale | 53.3K | $51.37 | $2.7M |
| Jun 8, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 3.5K | $50.00 | $173.6K |
| May 22, 2026 | Noubar Afeyan | Director | Sale | 9.3K | $46.84 | $433.9K |
| May 18, 2026 | Stephen Hoge | President | Sale | 53.3K | $48.40 | $2.6M |
| May 4, 2026 | Abbas Hussain | Director | Sale | 5.7K | $46.63 | $265.0K |
| Mar 3, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 13.9K | $52.29 | $726.0K |
| Feb 25, 2026 | Stephen Hoge | President | Sale | 160.0K | $48.84 | $7.8M |
| Dec 15, 2025 | Noubar Afeyan | Director | Sale | 23.9K | $29.49 | $703.3K |
| Dec 11, 2025 | Abbas Hussain | Director | Sale | 504 | $27.60 | $13.9K |
| Jun 12, 2025 | Abbas Hussain | Director | Sale | 312 | $28.00 | $8.7K |
| Mar 4, 2025 | Stephane Bancel | Chief Executive Officer | Purchase | 160.3K | $31.22 | $5.0M |
| Mar 4, 2025 | Paul Sagan | Director | Purchase | 31.6K | $31.76 | $1.0M |
| Dec 10, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 529 | $44.68 | $23.6K |
| Dec 4, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 112 | $43.30 | $4.8K |
| Dec 4, 2024 | Stephen Hoge | President | Sale | 314 | $43.30 | $13.6K |
| Dec 2, 2024 | James M Mock | Chief Financial Officer | Sale | 1.4K | $42.79 | $60.8K |
| Dec 2, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 1.4K | $42.79 | $60.7K |
| Dec 2, 2024 | Stephen Hoge | President | Sale | 291 | $42.79 | $12.5K |
| Nov 12, 2024 | Stephen Hoge | President | Sale | 277 | $46.10 | $12.8K |
| Oct 8, 2024 | James M Mock | Chief Financial Officer | Sale | 715 | $60.12 | $43.0K |
| Sep 10, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 551 | $73.57 | $40.5K |
| Sep 4, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 114 | $76.99 | $8.8K |
| Sep 4, 2024 | Stephen Hoge | President | Sale | 318 | $76.99 | $24.5K |
| Aug 30, 2024 | James M Mock | Chief Financial Officer | Sale | 162 | $78.03 | $12.6K |
Showing the 25 most recent of 821 Form 4 filings for Moderna, Inc..
Most active MRNA insiders
- Stephane Bancel266 filings
- Juan Andres145 filings
- Stephen Hoge145 filings
- Noubar Afeyan86 filings
- Tal Zvi Zaks73 filings
Ask anything about MRNA insider activity
Use Trabud's AI agent to query Moderna, Inc.'s Form 4 history in plain English — "Show me MRNA CEO purchases this year" or compare it against any other ticker.
Open the AI agentMRNA insider trading FAQ
Are Moderna, Inc. insiders buying or selling?
Across 821 SEC Form 4 filings, Moderna, Inc. (MRNA) insiders reported 3 open-market purchases totaling $7.0M and 818 sales totaling $3.7B. That is a net selling position of $3.7B.
How many insiders trade MRNA stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Moderna, Inc.. The most recent filing was accepted on Jul 16, 2026.
Where does Trabud get MRNA insider trading data?
All MRNA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.